Research Topics
Species | Bengt I ErikssonSummaryAffiliation: Sahlgrenska University Hospital Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson
University of Gothenburg, Gothenburg, Sweden
J Bone Joint Surg Br 91:636-44. 2009..3% vs 0.2%). Rivaroxaban started six to eight hours after surgery was more effective than enoxaparin started the previous evening in preventing symptomatic venous thromboembolism and all-cause mortality, without increasing major bleeding...
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: A pooled analysisBengt I Eriksson
Department of Ortopaedics, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, SE 43180 Molndal, Sweden Electronic address
Thromb Res 130:818-20. 2012..Obesity is an established independent risk factor for VTE...
Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trialsBengt I Eriksson
University Hospital Sahlgrenska, Gothenburg, Sweden
Thromb Res 130:396-402. 2012..Four Phase 3 trials of dabigatran etexilate in major orthopedic surgery incorporated measures to assess the risk of acute coronary syndrome (ACS) events during and after treatment...
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplastyBengt I Eriksson
Department of Orthopaedics, Sahlgrenska University Hospital Molndal, Molndal, Sweden
Thromb Res 130:147-51. 2012..This analysis compared the safety of concomitant use of specified medications with rivaroxaban and enoxaparin by evaluating postoperative bleeding rates from the pooled RECORD1-4 data...
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplastyBengt I Eriksson
Clin Orthop Relat Res 466:2009-11; author reply 2012-4. 2008
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacementBengt I Eriksson
Department of Orthopaedics, Sahlgrenska University Hospital Ostra, SE 416 85 Gothenburg, Sweden
Circulation 114:2374-81. 2006..Rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--could be an alternative to heparins and warfarin for the prevention and treatment of thromboembolic disorders...
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory studyB I Eriksson
Sahlgrenska University Hospital Ostra, Goteborg, Sweden
J Thromb Haemost 6:457-63. 2008..We investigated the anticoagulant potential of oral TTP889, a small molecule that inhibits up to 90% of FIXa activity at therapeutic doses, using a clinical model of extended prophylaxis in hip fracture surgery (HFS)...
Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitorsBengt I Eriksson
Department of Orthopaedic Surgery, Sahlgrenska University Hospital Ostra, SE 416 85 Goteborg, Sweden
Drugs 64:577-95. 2004..Ximelagatran can be used with an oral fixed dose without the need for coagulation monitoring or dose adjustment. Hence, it offers significant potential to facilitate the management of anticoagulation in or out of hospital...
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyB I Eriksson
Department of Orthopedics, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
J Thromb Haemost 1:2490-6. 2003..Ximelagatran and its subcutaneous (s.c.) form melagatran are novel direct thrombin inhibitors for the prevention and treatment of thromboembolic disease...
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplastyBengt I Eriksson
Sahlgrenska University Hospital Ostra, Gothenburg, Sweden
N Engl J Med 358:2765-75. 2008..This phase 3 trial compared the efficacy and safety of rivaroxaban, an oral direct inhibitor of factor Xa, with those of enoxaparin for extended thromboprophylaxis in patients undergoing total hip arthroplasty...
Clinical experience of melagatran/ximelagatran in major orthopaedic surgeryBengt I Eriksson
Department of Orthopaedic Surgery, Sahlgrenska University Ostra, Göteborg S 41685, Sweden
Thromb Res 109:S23-9. 2003..The METHRO II and III studies demonstrate that s.c. melagatran combined with oral ximelagatran are well tolerated and effective for the prevention of VTE following major orthopaedic surgery...
Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind studyBengt I Eriksson
Orthopedics Department, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Arch Intern Med 163:1337-42. 2003..The benefit of thromboprophylaxis for 1 month has never been evaluated in patients undergoing hip fracture surgery, a setting in the highest risk category for postoperative venous thromboembolism (VTE)...
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO IB I Eriksson
Sahlgrenska University Hospital Ostra, Goteborg, Sweden
J Thromb Haemost 2:1573-80. 2004..Following oral administration, dabigatran etexilate is rapidly converted to its active form dabigatran (BIBR 953 ZW)...
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trialBengt I Eriksson
Department of Orthopaedic Surgery, Sahlgrenska University Hospital Ostra, Gothenburg, Sweden
Lancet 370:949-56. 2007..After hip replacement surgery, prophylaxis following discharge from hospital is recommended to reduce the risk of venous thromboembolism. Our aim was to assess the oral, direct thrombin inhibitor dabigatran etexilate for such prophylaxis...
Clinical experience with ximelagatran in orthopaedic surgeryBengt Eriksson
Department of Orthopaedics, Sahlgrenska University Hospital Ostra, Gothenburg, Sweden
Drugs 64:27-35. 2004..As ximelagatran can be given in fixed oral dosing without coagulation monitoring, it is an attractive choice for the prevention of venous thromboembolism in major elective orthopaedic surgery...
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trialB I Eriksson
Sahlgrenska University Hospital Ostra, Gothenburg, Sweden
J Thromb Haemost 5:2178-85. 2007....
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trialB I Eriksson
Sahlgrenska University Hospital Ostra, Goteborg, Sweden
J Thromb Haemost 3:103-11. 2005..Dabigatran etexilate is an oral direct thrombin inhibitor undergoing evaluation for the prevention of venous thromboembolism (VTE) following orthopedic surgery...
Ximelagatran in orthopaedic surgeryBengt Eriksson
Department of Orthopedics, Sahlgrenska University Hospital Ostra, SE 41685 Gothenburg, Sweden
Pathophysiol Haemost Thromb 34:10-7. 2005....
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgeryB I Eriksson
Department of Orthopaedics, Sahlgrenska University Ostra Hospital, Gothenburg, Sweden
J Thromb Haemost 5:1660-5. 2007..YM150, a new oral direct factor Xa inhibitor is used as prophylaxis for venous thromboembolism (VTE), a well-known risk after orthopaedic surgery...
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacementB I Eriksson
Sahlgrenska University HospitalOstra, Gothenburg, Sweden
J Thromb Haemost 4:121-8. 2006..Joint replacement surgery is an appropriate model for dose-ranging studies investigating new anticoagulants...
Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacementBengt I Eriksson
Department of Orthopaedics, Sahlgrenska University Hospital Ostra, SU Ostra sjukhuset, SE 41685 Goteborg, Sweden
Thromb Res 120:685-93. 2007..Rivaroxaban (BAY 59-7939) is a novel, oral, direct Factor Xa inhibitor in clinical development for the prevention of thromboembolic disorders. The aim of this study was to demonstrate proof-of-principle for rivaroxaban...
Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in developmentBengt I Eriksson
Orthopaedics Department, University Hospital Sahlgrenska Ostra, Gothenburg, Sweden
Clin Pharmacokinet 48:1-22. 2009..Here, we compare the pharmacokinetic and pharmacodynamic features of these new oral agents...
Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgeryBengt I Eriksson
Department of Orthopaedics Surgery, Sahlgrenska University Hospital Ostra, Gothenburg, Sweden
Drugs 66:1411-29. 2006....
Novel oral factor Xa and thrombin inhibitors in the management of thromboembolismBengt I Eriksson
Department of Orthopaedics, Sahlgrenska University Hospital, Molndal, Sweden
Annu Rev Med 62:41-57. 2011..Edoxaban, an oral FXa inhibitor, is also being evaluated in phase III clinical trials. This review summarizes the pharmacology, clinical trial results, and future role of the new oral anticoagulants in clinical practice...
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgeryB I Eriksson
Orthopedics Department, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
N Engl J Med 345:1298-304. 2001..Surgery for hip fracture carries a high risk of venous thromboembolism, despite the use of current thromboprophylactic treatments. Fondaparinux, a synthetic pentasaccharide, is a new antithrombotic agent that may reduce this risk...
A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Bengt I Eriksson
Department of Orthopaedic Surgery, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Thromb Haemost 87:231-7. 2002..Ximelagatran and melagatran were well tolerated. In conclusion, ximelagatran and its active form melagatran appear to be promising agents for the prevention of venous thromboembolism following orthopaedic surgery...
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trialBengt I Eriksson
University of Gothenburg, Department of Orthopaedics, Sahlgrenska University Hospital, Molndal, Sweden
Thromb Haemost 105:721-9. 2011..The risk of bleeding and safety profiles were similar...
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)B I Eriksson
Department of Orthopaedics, Sahlgrenska University Hospital, Gothenburg, Sweden
J Thromb Haemost 8:714-21. 2010....
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trialBengt I Eriksson
Department of Orthopaedic Surgery, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Lancet 360:1441-7. 2002..We aimed to compare the efficacy and safety with that of dalteparin...
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacementBengt I Eriksson
Orthopaedics Department, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Thromb Haemost 89:288-96. 2003..0%) and 306/1122 (27.3%) patients in the ximelagatran and enoxaparin group, respectively, a difference in risk of 3.7% in favour of enoxaparin (p = 0.053). Bleeding was comparable between the two groups...
Major functional deficits persist 2 years after acute Achilles tendon ruptureNicklas Olsson
Department of Orthopaedics, Institute of Clinical Sciences at Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Sweden
Knee Surg Sports Traumatol Arthrosc 19:1385-93. 2011..The focus was to evaluate whether any improvements occurred between the one and 2-year evaluation...
Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studiesBengt I Eriksson
Department of Orthopaedic Surgery, Sahlgrenska University Hospital Ostra, S 41685, Goteborg, Sweden
Thromb Res 105:371-8. 2002..In conclusion, subcutaneous melagatran 1.5-4.5 mg bid in saline or depot formulation was well tolerated and resulted in a low frequency of VTE...
Pharmacokinetics of melagatran and the effect on ex vivo coagulation time in orthopaedic surgery patients receiving subcutaneous melagatran and oral ximelagatran: a population model analysisUlf G Eriksson
AstraZeneca R and D Molndal, Molndal, Sweden
Clin Pharmacokinet 42:687-701. 2003..To support the design of a pivotal dose-finding study, the impact of individualised dosage based on bodyweight and calculated creatinine clearance was examined...
A randomized, controlled study of a rehabilitation model to improve knee-function self-efficacy with ACL injuryPia Thomeé
Department of Orthopedics, Goteborg University, Goteborg, Sweden
J Sport Rehabil 19:200-13. 2010..Preoperative knee-function self-efficacy has also been shown to have a predictive ability in terms of outcome 1 y after ACL reconstruction...
Improvements in the prevention of postoperative venous thromboembolism in hip fracture patientsBengt I Eriksson
Department of Orthopedics, Sahlgrenska University Hospital/Ostra, , Sweden
Orthopedics 26:s851-8. 2003..4% (relative risk reduction: 95.9%; P<.001). Based on these findings, 4-week fondaparinux treatment may become the standard thromboprophylaxis after hip fracture surgery...
Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplastyBengt I Eriksson
Orthopedics Department, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Clin Appl Thromb Hemost 15:25S-31S. 2009..With the practical advantages of once-daily oral dosing, dabigatran etexilate can be considered an attractive alternative to conventional thromboprophylaxis regimens in patients undergoing elective total hip and knee arthroplasty...
A new surgical method to treat chronic ruptures and reruptures of the Achilles tendonKatarina Nilsson-Helander
Department of Orthopaedics, Kungsbacka Hospital, Goteborg University, Gamla Göteborgsvägen, 434 40, Kungsbacka, Sweden
Knee Surg Sports Traumatol Arthrosc 16:614-20. 2008..The use of a single incision in combination with a free flap augmentation produced favourable results...
Acute achilles tendon rupture: a randomized, controlled study comparing surgical and nonsurgical treatments using validated outcome measuresKatarina Nilsson-Helander
Katarina Nilsson Helander, Department of Orthopaedics, Kungsbacka Hospital, SE 434 40 Kungsbacka, Sweden
Am J Sports Med 38:2186-93. 2010..Few randomized controlled studies have compared outcomes after surgical or nonsurgical treatment with both groups receiving early mobilization...
Will early reconstruction prevent abnormal kinematics after ACL injury? Two-year follow-up using dynamic radiostereometry in 14 patients operated with hamstring autograftsJonas Isberg
Department of Orthopaedics, Sahlgrenska University Hospital Molndal, 413 80, Molndal, Sweden
Knee Surg Sports Traumatol Arthrosc 19:1634-42. 2011....
A new measurement of heel-rise endurance with the ability to detect functional deficits in patients with Achilles tendon ruptureKarin Gravare Silbernagel
Department of Orthopaedics, Institute of Clinical Sciences at Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
Knee Surg Sports Traumatol Arthrosc 18:258-64. 2010....
High incidence of deep venous thrombosis after Achilles tendon rupture: a prospective studyKatarina Nilsson-Helander
Department of Orthopaedics, Kungsbacka Hospital, Gamla Göteborgsvägen, Kungsbacka 434 40, Sweden
Knee Surg Sports Traumatol Arthrosc 17:1234-8. 2009..The incidence of asymptomatic and symptomatic deep venous thrombosis is high after Achilles tendon rupture and there is a need to define the possible benefit of thromboprophylaxis...
Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgeryK Wahlander
Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
Thromb Haemost 87:580-5. 2002..03 and p = 0.05, respectively). However, since 90% of the patients with these genetic risk factors will not suffer a VTE event, a general pre-operative genotyping is, in our opinion, of questionable value...
Efficacy of delayed thromboprophylaxis with dabigatran: pooled analysisBengt I Eriksson
Department of Orthopaedics, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, SE 43180 Molndal, Sweden
Thromb Res 130:871-6. 2012..However, a delay in dosing could occur for clinical or logistical reasons. A post hoc analysis was carried out to determine if patients with delayed dosing received adequate anticoagulation...
Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled studyKarin Gravare Silbernagel
Lundberg Laboratory of Orthopaedic Research, Department of Orthopaedics, Goteborg University, Sahlgrenska University Hospital, Gröna Stråket 12, 413 45 Goteborg, Sweden
Am J Sports Med 35:897-906. 2007..Achilles tendinopathy is a common overuse injury, especially among athletes involved in activities that include running and jumping. Often an initial period of rest from the pain-provoking activity is recommended...
The application of evidence-based measures to reduce surgical site infections during orthopedic surgery - report of a single-center experience in SwedenAnnette Erichsen Andersson
University of Gothenburg, The Sahlgrenska Academy, Institute of Health and Care Sciences, Gothenburg, Sweden
Patient Saf Surg 6:11. 2012..abstract:..
Full symptomatic recovery does not ensure full recovery of muscle-tendon function in patients with Achilles tendinopathyKarin Gravare Silbernagel
Sportrehab Physical Therapy and Sports Medicine Clinic, Goteborg, Sweden
Br J Sports Med 41:276-80; discussion 280. 2007..To assess the relationship between muscle-tendon function and symptoms in patients with Achilles tendinopathy using a validated test battery...
Determinants of self-efficacy in the rehabilitation of patients with anterior cruciate ligament injuryPia Thomeé
Lundberg Laboratory for Orthopaedic Research, Gröna Stråket 12, Sahlgrenska University Hospital, Goteborg, Sweden
J Rehabil Med 39:486-92. 2007..To explore physical and psychological measures believed to determine patients' perceived self-efficacy in the rehabilitation of patients with anterior cruciate ligament injury...
Self-efficacy of knee function as a pre-operative predictor of outcome 1 year after anterior cruciate ligament reconstructionPia Thomeé
Department of Orthopaedics, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden
Knee Surg Sports Traumatol Arthrosc 16:118-27. 2008....
Subacute versus delayed reconstruction of the anterior cruciate ligament in the competitive athleteJ Karlsson
Department of Orthopaedics, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Knee Surg Sports Traumatol Arthrosc 7:146-51. 1999..Furthermore, meniscal injuries were significantly more frequent if the reconstruction was delayed...
Is a knee brace advantageous after anterior cruciate ligament surgery? A prospective, randomised study with a two-year follow-upS Brandsson
Department of Orthopaedics, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Scand J Med Sci Sports 11:110-4. 2001..However, there were no differences in terms of function or knee laxity at the two-year follow-up...
Complications following arthroscopic anterior cruciate ligament reconstruction. A 2-5-year follow-up of 604 patients with special emphasis on anterior knee painJ Kartus
Department of Orthopaedics, Norra Alvsborgs County Hospital, Trollhattan, Sweden
Knee Surg Sports Traumatol Arthrosc 7:2-8. 1999..Anterior knee pain and problems with knee-walking were correlated with the loss of range of motion and anterior knee sensitivity...
Self-efficacy, symptoms and physical activity in patients with an anterior cruciate ligament injury: a prospective studyP Thomeé
Department of Orthopaedics, Sahlgrenska University Hospital, Goteborg, Sweden
Scand J Med Sci Sports 17:238-45. 2007..Furthermore, self-efficacy differed significantly with gender, age and physical activity level early in the rehabilitation process...
Analysis of subjective, objective and functional examination tests after anterior cruciate ligament reconstruction. A follow-up of 527 patientsN Sernert
Department of Orthopaedics, Northern Alvsborg Uddevalla County Hospital, Trollhattan, Sweden
Knee Surg Sports Traumatol Arthrosc 7:160-5. 1999..We conclude that the IKDC evaluation system is a reliable and useful tool for evaluating the post-operative outcome after an ACL reconstruction...
The Achilles tendon Total Rupture Score (ATRS): development and validationKatarina Nilsson-Helander
Lundberg Laboratory for Orthopaedic Research, Department of Orthopaedics, Sahlgrenska University Hospital, Goteborg University, Sweden
Am J Sports Med 35:421-6. 2007..There is a need for a patient-relevant instrument to evaluate outcome after treatment in patients with a total Achilles tendon rupture...
A new instrument for measuring self-efficacy in patients with an anterior cruciate ligament injuryP Thomeé
Department of Orthopaedics, Sahlgrenska University Hospital, Goteborg, Sweden
Scand J Med Sci Sports 16:181-7. 2006..The K-SES is recommended for studies designed to evaluate prognostic and outcome expectations of perceived self-efficacy in patients with an ACL-insufficient knee...
Magnetic resonance imaging of the patellar tendon after harvesting its central third: a comparison between traditional and subcutaneous harvesting techniquesJ Kartus
Department of Orthopaedics, Norra Alvsborg Hospital, Trollhattan, Sweden
Arthroscopy 15:587-93. 1999..0001). At 2-year follow-up, the subcutaneous graft-harvesting technique resulted in less disturbance of anterior knee sensitivity and a smaller donor-site gap than the traditional technique...
Kinematics after tear in the anterior cruciate ligament: dynamic bilateral radiostereometric studies in 11 patientsS Brandsson
Department of Orthopaedics, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Acta Orthop Scand 72:372-8. 2001..Changes in the kinematics of the knee joint due to rupture of the anterior cruciate ligament can result in an abnormal joint load, which may increase the risk of damage to the cartilage and the menisci...
Traffic flow in the operating room: an explorative and descriptive study on air quality during orthopedic trauma implant surgeryAnnette Erichsen Andersson
Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Am J Infect Control 40:750-5. 2012....
Early active extension after anterior cruciate ligament reconstruction does not result in increased laxity of the kneeJonas Isberg
Department of Orthopaedics, Sahlgrenska University Hospital, 416 85 Goteborg, Sweden
Knee Surg Sports Traumatol Arthrosc 14:1108-15. 2006....
Kinematics and laxity of the knee joint after anterior cruciate ligament reconstruction: pre- and postoperative radiostereometric studiesSveinbjörn Brandsson
Department of Orthopaedics, Sahlgrenska University Hospital, SE 416 85 Goteborg, Sweden
Am J Sports Med 30:361-7. 2002..In studies of cadaveric knees, investigators have examined the effect of anterior cruciate ligament reconstruction on knee kinematics, but the effect on dynamic knee motion is not known...
KT-1000 records smaller side-to-side differences than radiostereometric analysis before and after an ACL reconstructionJonas Isberg
Department of Orthopaedics, Sahlgrenska University Hospital, Goteborg University, 41685, Goteborg, Sweden
Knee Surg Sports Traumatol Arthrosc 14:529-35. 2006....
A prospective four- to seven-year follow-up after arthroscopic anterior cruciate ligament reconstructionS Brandsson
Department of Orthopaedics, Sahlgrenska University Hospital/Ostra, , Sweden
Scand J Med Sci Sports 11:23-7. 2001....
Intraarticular morphine after arthroscopic ACL reconstruction: a double-blind placebo-controlled study of 40 patientsS Brandsson
Department of Orthopedics, Sahlgrenska University Hospital Ostra, Goteborg, Sweden
Acta Orthop Scand 71:280-5. 2000..The analgesic effect of intraarticular morphine together with the low levels of morphine and morphine-6-glucuronide in plasma further strengthens the view that opioids have a peripheral mechanism of action...
Biodegradable and metallic interference screws in anterior cruciate ligament reconstruction surgery using hamstring tendon grafts: prospective randomized study of radiographic results and clinical outcomeGauti Laxdal
Department of Orthopaedics, Sahlgrenska University Hospital Ostra, SE 416 85 Goteborg, Sweden
Am J Sports Med 34:1574-80. 2006..The use of biodegradable screws in anterior cruciate ligament reconstruction has grown in popularity...
The localization of the infrapatellar nerves in the anterior knee region with special emphasis on central third patellar tendon harvest: a dissection study on cadaver and amputated specimensJ Kartus
Department of Orthopaedics, Norra Alvsborg Hospital, Trollhattan, Sweden
Arthroscopy 15:577-86. 1999....
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialAlexander G G Turpie
Department of Medicine, General Division, Hamilton Health Sciences Corporation, Ontario, Hamilton, Canada
Lancet 359:1721-6. 2002..We aimed to see whether the pentasaccharide fondaparinux, the first drug of a new class of synthetic antithrombotic agents, could reduce this risk to a greater extent than other available treatments...
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsAlexander G G Turpie
Department of Medicine, Hamilton Health Sciences General Hospital, 237 Barton St East, Hamilton, ON, L8L 2X2, Canada
Chest 126:501-8. 2004....
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparisonMichael Rud Lassen
Department of Orthopaedics, University Hospital of Copenhagen Hillerød, DK 3400, Hillerød, Denmark
Lancet 359:1715-20. 2002..We aimed to assess the ability of the pentasaccharide fondaparinux, the first of a new class of synthetic antithrombotic agents, to further reduce this risk...
FondaparinuxAlexander G G Turpie
Department of Medicine, Hamilton Health Sciences-Hamilton General Hospital and McMaster University, Hamilton, Ontario, Canada
J Am Acad Orthop Surg 12:371-5. 2004
Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplastyOla E Dahl
International Surgical Thrombosis Forum, Thrombosis Research Institute, London, UK
Pathophysiol Haemost Thromb 35:428-34. 2006..4-12 h) when compared with preoperative (12 h) administration of enoxaparin. Transfusion rates were significantly lower with administration of melagatran/ximelagatran compared with enoxaparin...
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studiesWilliam D Fisher
McGill University Health Centre, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4, Canada
Thromb Haemost 97:931-7. 2007..Overall, rivaroxaban total daily doses of 5-20 mg had the most favorable balance of efficacy and safety, relative to enoxaparin, for the prevention of VTE after major orthopaedic surgery...
Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysisKarl-Heinz Liesenfeld
Boehringer Ingelheim Pharma GmbH and Co, KG, Ingelheim, Germany
Br J Clin Pharmacol 62:527-37. 2006..Blood coagulation prolongation was most pronounced following surgery. Data suggest that ECT provides a more precise description of the anticoagulant effect than aPTT...
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolismKenneth A Bauer
VA Boston Healthcare System and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Curr Opin Pulm Med 8:398-404. 2002..Fondaparinux also appears to be a very promising candidate for the treatment of patients with existing VTE...
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studiesAlexander G G Turpie
Department of Medicine, Hamilton Health Sciences General Hospital, 237 Barton, Hamilton, Ontario, Canada L8L 2X2
Arch Intern Med 162:1833-40. 2002..Fondaparinux, the first of a new class of synthetic selective factor Xa inhibitors, may further reduce this risk compared with currently available thromboprophylactic treatments...
Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevanceAndreas Greinacher
Institute for Immunology and Transfusion Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany
Blood 101:2617-9. 2003..However, the total number of immunized patients observed was low and so infrequent (but severe) effects of antihirudin antibodies cannot be excluded...
Efficacy of fondaparinux for thromboprophylaxis in hip fracture patientsBengt I Eriksson
Sahlgrenska Univesrity Hospital/Ostra, , Sweden
J Arthroplasty 19:78-81. 2004..063). Risk of VTE was continued following short course fondaparinux in hip fracture patients, but was significantly reduced by extending prophylaxis, without significant risk of major bleeding...
Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacementJoachim Stangier
Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharma GmbH and Co KG, Birkendorfer Strasse, Biberach an der Riss, D-88397, Germany
J Clin Pharmacol 45:555-63. 2005..These pharmacokinetic characteristics confirm the suitability of this oral solid dosage form for use in future clinical trials...
Significantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparinBengt I Eriksson
Thromb Haemost 92:428-30. 2004
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studiesAlexander G G Turpie
Department of Medicine, Hamilton Health Sciences General Hospital, 237 Barton Street East, Hamilton, Ontario L8L 2X2, Canada
Chest 124:371S-378S. 2003..Fondaparinux has been recently approved for use in thromboprophylaxis after major orthopedic surgery. The clinical development of fondaparinux in other thromboprophylactic indications is ongoing...
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgeryWolfgang Mueck
Clinical Pharmacology, Bayer HealthCare AG, Aprather Weg 18a, Wuppertal, Germany
Clin Pharmacokinet 47:203-16. 2008....
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgeryAlexander G G Turpie
Lancet 362:1582-3. 2003
Fondaparinux, the first selective factor Xa inhibitorAlexander G G Turpie
Hamilton Health Sciences General Hospital, Hamilton, Ontario, Canada
Curr Opin Hematol 10:327-32. 2003..Finally, the efficacy and safety of fondaparinux in the treatment of venous thromboembolism and acute coronary syndromes appears promising...
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trialAjay K Kakkar
Barts and the London School of Medicine and Dentistry, London, UK
Lancet 372:31-9. 2008..Our aim was to compare the use of rivaroxaban for extended thromboprophylaxis with short-term thromboprophylaxis with enoxaparin...
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparinTheodore E Warkentin
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
Blood 106:3791-6. 2005..We conclude that despite similar immunogenicity of fondaparinux and LMWH, PF4/fondaparinux, but not PF4/LMWH, is recognized poorly by the antibodies generated, suggesting that the risk of HIT with fondaparinux likely is very low...
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacementWolfgang Mueck
Bayer HealthCare AG, Aprather Weg 18a, Wuppertal, Germany
Thromb Haemost 100:453-61. 2008....
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialistKenneth A Bauer
Department of Medicine, VA Boston Healthcare System and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
J South Orthop Assoc 11:197-202. 2002..Fondaparinux has demonstrated its efficacy compared to a widely used low-molecular-weight heparin in a number of thromboprophylaxis trials after major orthopedic surgery and is approved for use in this setting...
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgeryAlexander G G Turpie
Department of Medicine, Hamilton Health Sciences General Hospital, Hamilton, Ontario, Canada
J South Orthop Assoc 11:182-8. 2002..4%. The overall incidence of clinically relevant bleeding was low and did not differ between the two groups. The benefit of fondaparinux was consistent across all types of surgery and all subgroups...
Dabigatran etexilateBengt I Eriksson
Nat Rev Drug Discov 7:557-8. 2008
